Home > Executive Order

AI Summary: This is a policy document - specifically an Executive Order about lowering prescription drug prices. This regulation aims to reduce prescription drug prices through multiple strategies across federal healthcare programs. The executive order directs various federal agencies to take specific actions within set timeframes, including proposing improvements to the Medicare Drug Price Negotiation Program, developing plans to stabilize Medicare Part D premiums, creating mechanisms to better account for drug acquisition costs, promoting competition in drug markets, and increasing transparency in pharmaceutical pricing. Key focus areas include aligning treatment of small molecule and biological drugs, ensuring more accurate Medicaid drug rebates, accelerating generic drug approvals, streamlining drug importation, improving pharmacy benefit manager fee disclosure, and combating anti-competitive behaviors by pharmaceutical manufacturers. The order seeks to optimize federal health care programs, intellectual property protections, and safety regulations to provide lower-cost prescription drugs to American patients and taxpayers, with specific directives issued to the Departments of Health and Human Services, Labor, Justice, Commerce, and other federal agencies.